Association of E-selectin S128R polymorphism with hereditary breast carcinoma susceptibility in Turkish patients without BRCA1/2 germline mutations

1 Public Health Agency of Turkey, Department of Cancer, Cancer Registry in Turkey. Available from: http://kanser.gov.tr/daire-faaliyetleri/kanser-kayitciligi/108-tьrkiyede-kanser-kayitcigi.htmlPublic Health Agency of Turkey, Department of Cancer, Cancer Registry in TurkeyAvailable fromhttp://kanser.gov.tr/daire-faaliyetleri/kanser-kayitciligi/108-tьrkiyede-kanser-kayitcigi.htmlSearch in Google Scholar

2 McPherson K, Steel CM, Dixon JM. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ. 2000; 321(7261): 624-628.McPhersonKSteelCMDixonJMABC of breast diseasesBreast cancer-epidemiology, risk factors, and genetics. BMJ20003217261624–62810.1136/bmj.321.7261.624Search in Google Scholar

3 Petrucelli N, Daly MB, Pal T. BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer, 1998 [updated 2016]. In: Adam MP, Ardinger HH, Pagan RA, Wallace SE, Amemiya A, Bean LJH, et al., Eds. GeneReviews® [Internet]. Seattle (WA, USA): University of Washington, Seattle, WA, USA. (https://www.ncbi.nlm.nih.gov/pubmed/20301425.)PetrucelliNDalyMBPalTBRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer, 1998 [updated 2016]Adam MP, Ardinger HH, Pagan RA, Wallace SE, Amemiya A, Bean LJH, et al., EdsGeneReviews® [Internet]Seattle (WA, USA)University of Washington, Seattle, WA, USA(https://www.ncbi.nlm.nih.gov/pubmed/20301425.)Search in Google Scholar

4 Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998; 62(3): 676-689.FordDEastonDFStrattonMNarodSGoldgarDDevileePGenetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer familiesThe Breast Cancer Linkage Consortium. Am J Hum Genet1998623676–68910.1086/301749Search in Google Scholar

5 Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet. 1995; 56(1): 265-271.EastonDFFordDBishopDTBreast and ovarian cancer incidence in BRCA1-mutation carriersBreast Cancer Linkage Consortium. Am J Hum Genet1995561265–271Search in Google Scholar

6 Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet. 2003; 72(5): 1117-1130.AntoniouAPharoahPDNarodSRischHAEyfjordJEHopperJLAverage risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studiesAm J Hum Genet20037251117–113010.1086/375033Search in Google Scholar

7 Smith A, Moran A, Boyd MC, Bulman M, Shenton A, Smith L, et al. Phenocopies in BRCA1 and BRCA2 families: Evidence for modifier genes and implications for screening. J Med Genet. 2007; 44(1): 10-15.SmithAMoranABoydMCBulmanMShentonASmithLPhenocopies in BRCA1 and BRCA2 families: Evidence for modifier genes and implications for screeningJ Med Genet200744110–1510.1136/jmg.2006.043091Search in Google Scholar

8 Laubli H, Borsig L. Selectins promote tumor metastasis. Semin Cancer Biol. 2010; 20(3): 169-177.LaubliHBorsigLSelectins promote tumor metastasisSemin Cancer Biol2010203169–17710.1016/j.semcancer.2010.04.005Search in Google Scholar

9 Ley K. The role of selectins in inflammation and disease. Trends Mol Med. 2003; 9(6): 263-268.LeyKThe role of selectins in inflammation and diseaseTrends Mol Med200396263–26810.1016/S1471-4914(03)00071-6Search in Google Scholar

10 Krause T, Turner GA. Are selectins involved in metastasis? Clin Exp Metastasis. 1999; 17(3): 183-192.KrauseTTurnerGAAre selectins involved in metastasis?Clin Exp Metastasis1999173183–19210.1023/A:1006626500852Search in Google Scholar

11 Khatib AM, Fallavollita L, Wancewicz EV, Monia BP, Brodt P. Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis. Cancer Res. 2002; 62(19): 5393-5398.KhatibAMFallavollitaLWancewiczEVMoniaBPBrodtPInhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasisCancer Res200262195393–5398Search in Google Scholar

12 Laferriere J, Houle F, Taher MM, Valerie K, Huot J. Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells. J Biol Chem. 2001; 276(36): 33762-33772.LaferriereJHouleFTaherMMValerieKHuotJTransendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cellsJ Biol Chem20012763633762–3377210.1074/jbc.M00856420011448946Search in Google Scholar

13 Bal N, Kocer NE, Ertorer ME, Canpolat ET, Kayaselcuk F. Maspin, E-selectin, and P-selectin expressions in papillary thyroid carcinomas and their correlation with prognostic parameters. Pathol Res Pract. 2008; 204(10): 743-750.BalNKocerNEErtorerMECanpolatETKayaselcukFMaspin, E-selectin, and P-selectin expressions in papillary thyroid carcinomas and their correlation with prognostic parametersPathol Res Pract200820410743–75010.1016/j.prp.2008.04.01618597952Search in Google Scholar

14 Banks RE, Gearing AJ, Hemingway IK, Norfolk DR, Perren TJ, Selby PJ. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer. 1993; 68(1): 122-124.BanksREGearingAJHemingwayIKNorfolkDRPerrenTJSelbyPJCirculating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignanciesBr J Cancer1993681122–12410.1038/bjc.1993.29819683217686390Search in Google Scholar

15 Dymicka-Piekarska V, Kemona H. Does colorectal cancer clinical advancement affect adhesion molecules (sP-selectin, sE-selectin and ICAM-1) concentration? Thromb Res. 2009; 124(1): 80-83.Dymicka-PiekarskaVKemonaHDoes colorectal cancer clinical advancement affect adhesion molecules (sP-selectin, sE-selectin and ICAM-1) concentration?Thromb Res2009124180–8310.1016/j.thromres.2008.11.021Search in Google Scholar

16 Ke JJ, Shao QS, Ling ZQ. Expression of E-selectin, integrin β1 and immunoglobulin superfamily member in human gastric carcinoma cells and its clinicopathologic significance. World J Gastroenterol. 2006; 12(22): 3609-3611.KeJJShaoQSLingZQExpression of E-selectin, integrin β1 and immunoglobulin superfamily member in human gastric carcinoma cells and its clinicopathologic significanceWorld J Gastroenterol200612223609–361110.3748/wjg.v12.i22.3609Search in Google Scholar

17 Revelle BM, Scott D, Beck PJ. Single amino acid residues in the E- and P-selectin epidermal growth factor domains can determine carbohydrate binding specificity. J Biol Chem. 1996; 271(11): 16160-16170.RevelleBMScottDBeckPJSingle amino acid residues in the E- and P-selectin epidermal growth factor domains can determine carbohydrate binding specificityJ Biol Chem19962711116160–1617010.1074/jbc.271.27.16160Search in Google Scholar

18 Alexiou D, Karayiannakis AJ, Syrigos KN, Zbar A, Sekara E, Michail P, et al. Clinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in gastric cancer patients. Am J Gastroenterol. 2003; 98(2): 478-485.AlexiouDKarayiannakisAJSyrigosKNZbarASekaraEMichailPClinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in gastric cancer patientsAm J Gastroenterol2003982478–48510.1111/j.1572-0241.2003.07259.xSearch in Google Scholar

19 Reference SNP (refSNP) Cluster Report: rs5361. Available from: http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=5361Reference SNP (refSNP) Cluster Report: rs5361. Available fromhttp://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=5361Search in Google Scholar

20 Rao RM, Clarke JL, Ortlepp S, Robinson MK, Landis RC, Haskard DO. The S128R polymorphism of E-selectin mediates neuraminidase-resistant tethering of myeloid cells under shear flow. Eur J Immunol. 2002; 32(1): 251-260.RaoRMClarkeJLOrtleppSRobinsonMKLandisRCHaskardDOThe S128R polymorphism of E-selectin mediates neuraminidase-resistant tethering of myeloid cells under shear flowEur J Immunol2002321251–26010.1002/1521-4141(200201)32:1<251::AID-IMMU251>3.0.CO;2-0Search in Google Scholar

21 Rao RM, Haskard DO, Landis RC. Enhanced recruitment of Th2 and CLA-negative lymphocytes by the S128R polymorphism of E-selectin. J Immunol. 2002; 169(10): 5860-5865.RaoRMHaskardDOLandisRCEnhanced recruitment of Th2 and CLA-negative lymphocytes by the S128R polymorphism of E-selectinJ Immunol2002169105860–586510.4049/jimmunol.169.10.5860Search in Google Scholar

22 Wenzel K, Hanke R, Speer A. Polymorphism in the human E-selectin gene detected by PCR-SSCP. Hum Genet. 1994; 94(4): 452-453.WenzelKHankeRSpeerAPolymorphism in the human E-selectin gene detected by PCR-SSCPHum Genet1994944452–45310.1007/BF00201614Search in Google Scholar

23 Cheng DY, Hao YW, Zhou WL, Ma YR. E-selectin S128R polymorphism is associated with cancer risk: A meta-analysis. Asian Pac J Cancer Prev. 2014; 15(7): 3247-3252.ChengDYHaoYWZhouWLMaYRE-selectin S128R polymorphism is associated with cancer risk: A meta-analysisAsian Pac J Cancer Prev20141573247–325210.7314/APJCP.2014.15.7.3247Search in Google Scholar

24 NCCN Guideline. Genetic/Familial High-Risk Assessment: Breast and Ovarian Version 1, 2018. Professional version available from (subscription needed): https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdfNCCN GuidelineGenetic/Familial High-Risk Assessment: Breast and Ovarian Version 1, 2018. Professional version available from (subscription needed)https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdfSearch in Google Scholar

25 Xia HZ, Du WD, Wu Q, Chen G, Zhou Y, Tang XF, et al. E-selectin rs5361 and FCGR2A rs1801274 variants were associated with increased risk of gastric cancer in a Chinese population. Mol Carcinog. 2012; 51(8): 597-607.XiaHZDuWDWuQChenGZhouYTangXFE-selectin rs5361 and FCGR2A rs1801274 variants were associated with increased risk of gastric cancer in a Chinese populationMol Carcinog2012518597–60710.1002/mc.20828Search in Google Scholar

26 Liarmakopoulos E, Gazouli M, Aravantinos G, Theodoropoulos G, Rizos S, Vaiopoulou A, et al. E-Selectin S128R gene polymorphism in gastric cancer. Int J Biol Markers. 2013; 28(1): 38-42.LiarmakopoulosEGazouliMAravantinosGTheodoropoulosGRizosSVaiopoulouAE-Selectin S128R gene polymorphism in gastric cancerInt J Biol Markers201328138–4210.5301/JBM.2012.9582Search in Google Scholar

27 Hebbar M, Adenis A, Revillion F, Duhamel A, Romano O, Truant S, et al. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer. Eur J Cancer. 2009; 45(10): 1871-1876.HebbarMAdenisARevillionFDuhamelARomanoOTruantSE-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancerEur J Cancer200945101871–187610.1016/j.ejca.2009.03.01119361981Search in Google Scholar

28 Panoussopoulos GS, Theodoropoulos G, Michalopoulos NV, Gazouli M, Flessas J, Taka S, et al. Analysis of E-Selectin S128R gene polymorphism in pancreatic cancer. J Surg Oncol. 2010; 102(6): 604-607.PanoussopoulosGSTheodoropoulosGMichalopoulosNVGazouliMFlessasJTakaSAnalysis of E-Selectin S128R gene polymorphism in pancreatic cancerJ Surg Oncol20101026604–60710.1002/jso.2164820607758Search in Google Scholar

29 Kontogianni P, Zambirinis CP, Theodoropoulos G, Gazouli M, Michalopoulos NV, Flessas J, et al. The impact of the stromal cell-derived factor-1-3’A and E-selectin S128R polymorphisms on breast cancer. Mol Biol Rep. 2013; 40(1): 43-50.KontogianniPZambirinisCPTheodoropoulosGGazouliMMichalopoulosNVFlessasJThe impact of the stromal cell-derived factor-1-3’A and E-selectin S128R polymorphisms on breast cancerMol Biol Rep201340143–5010.1007/s11033-012-1989-x23129313Search in Google Scholar

30 Naidu R, Har YC, Taib NA. Polymorphic variant Ser128Arg of E-Selectin is associated with breast cancer risk and high grade tumors. Onkologie. 2011; 34(11): 592-597.NaiduRHarYCTaibNAPolymorphic variant Ser128Arg of E-Selectin is associated with breast cancer risk and high grade tumorsOnkologie20113411592–59710.1159/00033406022104155Search in Google Scholar